期刊文献+

质子泵抑制剂在经皮冠状动脉介入治疗术后抗血小板治疗中的价值 被引量:7

Value of proton pump inhibitors in the antiplatelet therapy after percutaneous coronary intervention
在线阅读 下载PDF
导出
摘要 目的探讨质子泵抑制剂(proton pump inhibitor,PPI)对经皮冠状动脉介入治疗术(PCI)后抗血小板治疗中上消化道出血及不良心血管事件(MACCE)发生的影响。方法选择在襄阳市中心医院心血管内科行PCI术的患者364例,术前、术后均给予氯吡格雷联合阿司匹林抗血小板治疗,随机分为3组:奥美拉唑组(n=121)、埃索美拉唑组(n=133)、对照组(n=110)。随访12个月,观察各组患者上消化道出血和MACCE的发生率。结果奥美拉唑组、埃索美拉唑组、对照组上消化道出血发生率分别为2.48%、1.50%、10.91%,MACCE发生率分别为:9.09%、8.27%、8.18%。对照组的上消化道出血发生率显著高于奥美拉唑组和埃索美拉唑组,差异有统计学意义(P<0.01),而奥美拉唑组和埃索美拉唑组间的上消化道出血发生率差异无统计学意义(P>0.05)。3组间的MACCE发生率差异无统计学意义(P>0.05)。结论奥美拉唑与埃索美拉唑可预防对PCI后抗血小板治疗患者上消化道出血的发生,二者均不增加MACCE的发生率。 Objective To investigate the effect of proton pump inhibitors (PPI) on upper gartrointestinal bleeding and major adverse cardiovascular events (MACCE) in the antiplatelet therapy after pereutaneous coronary intervention (PCI). Methods A total of 364 patients treated with clopidogrel and aspirin before and after PCI were randomly divid- ed into three group: omeprazol group (n = 121 ), esomeprazole group (n = 133 ) and control group (n = 110). The inci- dence rates of upper gartrointestinal bleeding and MACCE were observed. Results The incidence rates of upper gartroi- ntestinal bleeding in omeprazol group, esomeprazole group and control group were 2.48% , 1.50% , 10.91% , respce- tively, and the MACCE incidence rates were 9.09% , 8.27% , 8.18% , respcetively. The incidence rate of upper gart- rointestinal bleeding in control group was significantly higher than that in omeprazol group and esomeprazole group ( P 〈 0.05 ) , however, there was no significant difference between omeprazol group and esomeprazole group ( P 〉 0.05 ) ; there was no significant difference in MACCE incidence among 3 groups (P 〉 0.05). Conclusion Omeprazol and es- omeprazole decrease the incidence of upper gartrointestinal bleeding in patients after PCI, and do not increase the inci- dence of MACCE.
作者 刘娟 占义军
出处 《胃肠病学和肝病学杂志》 CAS 2013年第12期1244-1246,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 质子泵抑制剂 经皮冠状动脉介入治疗术 上消化道出血 氯吡格雷 Proton pump inhibitors Pereutaneous coronary intervention Upper gartrointestinal bleeding Clopidogrel
  • 相关文献

参考文献8

  • 1Levine GM,Bates ER,Blankenship JC. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention:executive summary:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J].Journal of the American College of Cardiology,2012,(11):1042-1042.
  • 2Siller-Matula JM,Jilma B,Schr(o)r K. effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel:a systematic review and meta-analysis[J].Journal of Thrombosis and Haemostasis,2010,(12):2624-2641.
  • 3崔海宏,韩英,曹建彪,李恕军,高革,范如英,杨欣艳,王继恒.抑酸药治疗使用阿司匹林、氯吡格雷的高危患者再次消化道出血的系统评价[J].胃肠病学和肝病学杂志,2008,17(10):840-843. 被引量:11
  • 4Ho PM,Maddox TM,Wang L. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[J].Journal of the American Medical Association,2009,(09):937-944.
  • 5Pezalla E,Day D,Pulliadath I. Initial assessment of clinical impact of drug interaction between clopidogrel and proton pump inhibitors[J].Journal of the American College of Cardiology,2008,(12):1038-1039.
  • 6Sibbing D,Morath T,Stegherr J. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel[J].Thrombosis and Haemostasis,2009,(04):714-719.
  • 7O'Donoghue ML,Braunwald E,Antman EM. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor:an analysis of two randomised trials[J].The Lancet,2009,(9694):989-997.doi:10.1016/S0140-6736(09)61525-7.
  • 8Blume H,Donath F,Warnke A. Pharmacokinetic drug interaction profiles of proton pump inhibitors[J].Drug Safety,2006,(09):769-784.doi:10.2165/00002018-200629090-00002.

二级参考文献12

  • 1Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding [ J]. N Engl J Med, 2005, 352(3 ) :238-244.
  • 2Ibanez L, Vidal X, Vendrell L, et al. Upper gastrointestinal bleeding associated with antiplatelet drugs [ J ]. Aliment Pharmacol Ther, 2006, 23 ( 2 ) :235-242.
  • 3Ng FH, Wong BC, Wong SY, ct al. Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk-a single-blind, randomized controlled study [J]. Aliment Pharmacol Ther, 2004, 19(3) :359-365.
  • 4Lai KC, Chu KM, Hui WM, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastroinlestinal ulcer complications [ J ]. Clin Gastroenterol Hepatol, 2006,4 (7) :860-865.
  • 5Ng FH, Wong SY, Chang CM, et al. High incidence of clopidogrel-assoeiated gastrointestinal bleeding in patients with previous peptic ulcer disease [J]. Aliment Pharmacol Ther, 2003, 18(4): 443-449.
  • 6Delaney JA, Opatrny L, Brophy JM, et al. Drug drug interactions between antithrombotie medications and the risk of gastrointestinal bleeding [J]. CMAJ, 2007, 177(4): 347-351.
  • 7Lanas A, Garcla-Rodriguez LA, Arroyo MT,et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations [ J ]. Gut, 2006, 55 (12) : 1731-1738.
  • 8Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study [ J ]. BMJ, 2006, 333 (7571) : 726.
  • 9CAPRIE Study Organisation. Steering Committee: Gent M, Beaumont D, Blanchard J, et al. A randomised, blinded, trial of clopidogrel versus. aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steerinz Committee [ J]. Lancet, 1996, 348(9038 ) : 1329-1339.
  • 10Reed JF 3rd. Homogeneity of kappa statistics in multiple samples [ J]. Comput Methods Programs Biomed, 2000, 63 ( 1 ) :43-46.

共引文献10

同被引文献80

  • 1钟飞鹏,韦继政.不同质子泵抑制剂应对阿斯匹林与氯吡格雷在治疗急性冠状动脉综合征的影响[J].医学信息(医学与计算机应用),2014,0(12):290-290. 被引量:2
  • 2张微微.比较氯吡格雷与阿司匹林加埃索美拉唑对复发性溃疡出血的预防作用的点评[J].实用心脑肺血管病杂志,2006,14(1):22-22. 被引量:3
  • 3程晓,张宏亮.阿莫西林联合两种质子泵抑制剂治疗胃溃疡临床疗效分析[J].中国保健营养(上旬刊),2014,4(上):2241.
  • 4Barkun A N, Bardou M, Kuipers E J.International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleedlng[J].Annals of Internal Medicine, 2010, 152(2): 101-113.
  • 5Chan F K, Wong V W, Suen B Y.Combination of a cyclo- oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk- a double-blind,.
  • 6Nadatani Y, Watanabe T, Tanigawa T, Sogawa M, Yamagami H, Shiba M, Watanabe K, Tominaga K, Fujiwara Y, Yoshiyama M, Arakawa T. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan. Scand J Gastroenterol 2013; 48:320-325 [PMID: 23298342 DOh 10.3109/00365521.2012.758771].
  • 7Kreutz RP, Stanek EJ, Aubert R, Yao J, Breall JA, Desta Z, Skaar TC, Teagarden JR, Frueh FW, Epstein RS, Flockhart DA. Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study. Pharmacotherapy 2010; 30:787-796 [PMID: 20653354 DOI: 10.1592/phco.30.8.787].
  • 8Chen YL, Chang CL, Chen HC, Sun CK, Yeh KH, Tsai TH, Chen CJ, Chen SM, Yang CH, Hang CL, Wu CJ, Yip HK. Major adverse upper gastrointestinal events in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention and dual antiplatelet therapy. Am J Cardiol 2011; 108:1704-1709 [PMID: 21924391 DOI: 10.1016/j.amjcard.2011.07.039].
  • 9Bhurke SM, Martin BC, Li C, Franks AM, Bursac Z, Said Q. Effect of the clopidogrel-proton pump inhibitor drug interaction on adversecardiovascular events in patients with acute coronary syndrome. Pharmacotherapy 2012; 32: 809-818 [PMID: 22744772 DOI: 10.1002/j.1875- 9114.2012.01112.x].
  • 10Wallace MC, Rankin J, Forbes GM. Acute gastrointestinal bleeding after percutaneous coronary intervention. Expert Rev Gastroenterol Hepatol 2012; 6:211-221 [PMID: 22375526 DOI: 10.1586/egh.11.104].

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部